Viewing Study NCT01574235


Ignite Creation Date: 2025-12-24 @ 10:04 PM
Ignite Modification Date: 2025-12-27 @ 6:06 AM
Study NCT ID: NCT01574235
Status: COMPLETED
Last Update Posted: 2015-07-28
First Post: 2012-04-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents
Sponsor: Hospira, now a wholly owned subsidiary of Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module